Publications by authors named "Jason B Brayer"

Claim this Profile
E
Epigenetic Plasticity Drives Carcinogenesis and Multi-Therapy Resistance in Multiple Myeloma.
Rafael Renatino Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads, Maria Silva, Xiaohong Zhao, Jason B Brayer

Res Sq· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK): haematological cohorts of the dose escalation segment of a phase 1 trial.
David A Sallman, Tessa Kerre, Violaine Havelange, Xavier Poiré, Philippe Lewalle, Jason B Brayer

Lancet Haematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma.
Jennifer M Logue, Lauren C Peres, Hamza Hashmi, Christelle M Colin-Leitzinger, Alexandria M Shrewsbury, Jason B Brayer

Blood Adv· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour types.
Caroline Lonez, Bikash Verma, Alain Hendlisz, Philippe Aftimos, Ahmad Awada, Jason B Brayer

BMJ Open· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing strategies in the immunotherapy of leukemias.
Jason B Brayer, Javier Pinilla-Ibarz

Cancer Control· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis